Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral and 5% Topical Tranexamic Acid in Monotherapy Compared With 4% Topical Hydroquinone for the Treatment of Melasma: Three-arm Randomized, Double-blinded Clinical Trial

NCT03585179 is registered in ClinicalTrials.gov with Centro Dermatológico Dr. Ladislao de la Pascua as lead sponsor.

NCT NCT03585179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03585179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral and 5% Topical Tranexamic Acid in Monotherapy Compared With 4% Topical Hydroquinone for the Treatment of Melasma: Three-arm Randomized, Double-blinded Clinical Trial
Lead sponsor
Centro Dermatológico Dr. Ladislao de la Pascua
Phase
Phase 3
Overall status
Unknown status
Start date
August 1, 2018
Completion date
June 1, 2020
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chloasma, melanosis, melasma